Baseline Characteristics According to Sex

Slides:

Advertisements

Similar presentations

Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]

Advertisements

Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:

Trial profile Fox K et al. Lancet 2008;372:

Slide Source: Lipids Online Slide Library Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients.

HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:

The Prospective Pravastatin Pooling Project L I P I D CARECARE PPP Project Investigators Am J Cardiol 1995; 76:899–905.

Enrollment, Randomization, and Follow-up of Study Participants ADVANCE Collaborative Group. N Engl J Med 2008;358:

Kastelein JJ, et al. Circulation 2008;117: On-Treatment Values of Lipids, Apolipoproteins, and Their Ratios in Both Treatment Groups of TNT and IDEAL.

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

Baseline Characteristics of 1994 of Men With Incident CHD (1994 to 2000) and Matched Control Subjects From the Health Professionals Follow-up Study T.

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.

Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nonfasting Glucose, Ischemic Heart Disease, and.

An analysis of 22,672 patients from the CLARIFY registry

Discontinuation of medication after nonfatal event: MI

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial Michael Miller MD,

Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:

Baseline Demographic and Clinic Variables According to Office vs 24-Hour or Home BP Giuseppe Mancia, et al. Hypertension 2006;47;

All-cause mortality by treatment group

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Pravastatin in Elderly Individuals at Risk of Vascular Disease

Copyright © 2007 American Medical Association. All rights reserved.

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in Finland by Gang Hu, Noël C. Barengo, Jaakko Tuomilehto,

Association of blood lipids with AF

Baseline characteristics of patients

Prevalence of statin and beta-blocker use by clinical presentation

Diabetes hazard rates by number of visits with reported statin use.

Fellström BC, et al. N Engl J Med 2009;360:1455-7

Relative risk of hypertension by quintiles of lipids (mg/dL)

Description of studies for pooled analyses

Hazard ratios for the primary end point by subgroup of achieved LDL cholesterol (adjusted for age, sex, baseline calculated LDL cholesterol, diabetes,

Q.A. Truong et al. Circ Cardiovasc Qual Outcomes 2011;4:

Baseline characteristics of CACTI type 1 diabetic subjects with cystatin C measurements (n=509), stratified by CAC progression status Maahs DM et al.

Daan Kromhout, et al. NEJM epub August 29, 2010

Baseline Characteristics by Tertiles of Homocysteine

Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31.

Baseline Characteristics of the Study Participants

Baseline Characteristics of the Subjects*

Rahilly-Tierney CR et al. Circulation 2009;120:1491-7

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Baseline Characteristics

Women’s Health Study: Baseline Characteristics Part 1

Jeffrey S. Berger, et al. Circ Cardiovasc Qual Outcomes 2009;2:78-87

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Baseline Lipid Parameters and Characteristics Among 3110 Men According to Quintiles of Total Cholesterol Ruben O. Halperin et al, Hypertension 2006;47;45-50.

Baseline Characteristics of the Patients – Part I

Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.

Baseline Characteristics by hs-CRP

PROSPER: trial design

Relationships between annual antibiotic purchase rates and progression of microalbuminuria in patients with type 1 diabetes. Relationships between annual.

The ACCORD Study Group. NEJM 2010; Epub March 14

Comparison of Baseline Characteristics by Primary End Point

Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients Kim et al. Am J Nephrol 2016;44:71-80.

Associations between type of MI and incident HF

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

HRs for prostate cancer by medication status.

Lifetime heart failure risk*

A: Mean wall motion score index (95% CI) in patients with first myocardial infarction segregated by Hp type. A: Mean wall motion score index (95% CI) in.

Christian Madelaire et al. JCHF 2018;6:

Adjusted HRs (95% CIs) for all-cause mortality associated with BMI by smoking status in men and women and by CHD, type 2 diabetes, and cancer status at.

Adjusted HRs (95% CIs) for all-cause mortality associated with body fat percentage by smoking status in men and women and by CHD, type 2 diabetes, and.

Frankel DS, et al. J Am Coll Cardiol. 2009;53:754-62

Associations between biomarkers of subclinical inflammation and progression of DSPN assessed by changes in MNSI in individuals with DSPN in KORA F4/FF4.

Adjusted all-cause (A) and CVD (B) mortality HRs (95% CIs) for IFG, IGT, NDM, and KDM compared with NGT according to ethnic group. Adjusted all-cause (A)

Risk of type 2 diabetes as a function of ABCA1 and ABCG1 genotype in CCHS. Hazard ratios were multifactorially adjusted for age, sex, BMI, hypertension,

Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference. Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference.

HR for myocardial infarction.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

Baseline Characteristics According to Sex Mizuno K. et al. Circulation 2008;117:494-502

Lipid Profiles During the Study Periods in Women Mizuno K. et al. Circulation 2008;117:494-502

Kaplan–Meier curves for major end points in men and women Kaplan–Meier curves for major end points in men and women. MI indicates myocardial infarction Mizuno K. et al. Circulation 2008;117:494-502

Heterogeneity for major end points between men and women Square size indicates the event incidence rate Mizuno K. et al. Circulation 2008;117:494-502

End Points in Women Mizuno K. et al. Circulation 2008;117:494-502

Incidence of major end points according to age group in women during the 5-year follow-up Mizuno K. et al. Circulation 2008;117:494-502

Cancers in Women Mizuno K. et al. Circulation 2008;117:494-502

Relationship between major end points and aging for women and the effect of pravastatin †HR was calculated with the Cox proportional-hazards model adjusted by age, HDL-C level, hypertension, and diabetes Mizuno K. et al. Circulation 2008;117:494-502

Mizuno K. et al. Circulation 2008;117:494-502